Genetic variations in RORα are associated with chronic obstructive pulmonary disease

Journal of Human Genetics

Volumn 59, Issue 8, 2014, Pages 430-436

  Yuan, Yiming ^a   Hou, Xiaoming ^a   Zhang, Jinlong ^a   Chen, Yulong ^a   Feng, Yulin ^a   Su, Zhiguang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID RELATED ORPHAN RECEPTOR ALPHA; RORA PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK;

EID: 84906698334     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2014.48     Document Type: Article

References (44)

1. Murray, C. J. & Lopez, A. D. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 274, 740-743 (1996).
2. Zhong, N., Wang, C., Yao, W., Chen, P., Kang, J., Huang, S. et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am. J. Respir. Crit. Care. Med. 176, 753-760 (2007).
3. Pauwels, R. A. & Rabe, K. F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364, 613-620 (2004).
4. Khoury, M. J., Beaty, T. H., Tockman, M. S., Self, S. G. & Cohen, B. H. Familial aggregation in chronic obstructive pulmonary disease: use of the loglinear model to analyze intermediate environmental and genetic risk factors. Genet. Epidemiol. 2, 155-166 (1985).
5. Shi, W., Chen, F. & Cardoso, W. V. Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 6, 558-563 (2009).
6. Castaldi, P. J., Cho, M. H., Cohn, M., Langerman, F., Moran, S., Tarragona, N. et al. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum. Mol. Genet. 19, 526-534 (2010).
7. Cho, M. H., Boutaoui, N., Klanderman, B. J., Sylvia, J. S., Ziniti, J. P., Hersh, C. P. et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat. Genet. 43, 200-202 (2010).
8. Pillai, S. G., Ge, D., Zhu, G., Kong, X., Shianna, K. V., Need, A. C. et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 5, e1000421 (2009).
9. Wilk, J. B., Chen, T. H., Gottlieb, D. J., Walter, R. E., Nagle, M. W., Brandler, B. J. et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet. 5, e1000429 (2009).
10. Soler Artigas, M., Wain, L. V., Repapi, E., Obeidat, M., Sayers, I., Burton, P. R. et al. Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am. J. Respir. Crit. Care. Med. 184, 786-795 (2011).
11. Nillawar, A. N., Joshi, K. B., Patil, S. B., Bardapurkar, J. S. & Bardapurkar, S. J. Evaluation of HS-CRP and Lipid Profile in COPD. J. Clin. Diagn. Res. 7, 801-803 (2013).
12. Burkart, K. M., Manichaikul, A., Wilk, J. B., Ahmed, F. S., Burke, G. L., Enright, P. et al. APOM and high-density lipoprotein are associated with lung function and percent emphysema. Eur. Respir. J. 43, 1007-1017 (2013).
13. Reed, R. M., Iacono, A., DeFilippis, A., Eberlein, M., Girgis, R. E. & Jones, S. Advanced chronic obstructive pulmonary disease is associated with high levels of high-density lipoprotein cholesterol. J. Heart Lung Transplant. 30, 674-678 (2011).
14. Iribarren, C., Jacobs, D. R. Jr., Sidney, S., Claxton, A. J., Gross, M. D., Sadler, M. et al. Serum total cholesterol and risk of hospitalization, and death from respiratory disease. Int. J. Epidemiol. 26, 1191-1202 (1997).
15. Tisi, G. M., Conrique, A., Barrett-Connor, E. & Grundy, S. M. Increased high density lipoprotein cholesterol in obstructive pulmonary disease (predominant emphysematous type). Metabolism 30, 340-346 (1981).
16. Giguere, V., Tini, M., Flock, G., Ong, E., Evans, R. M. & Otulakowski, G. Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev. 8, 538-553 (1994).
17. Solt, L. A. & Burris, T. P. Action of RORs and their ligands in (patho)physiology. Tr e n d s Endocrinol. Metab. 23, 619-627 (2012).
18. Kallen, J. A., Schlaeppi, J. M., Bitsch, F., Geisse, S., Geiser, M., Delhon, I. et al. X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure 10, 1697-1707 (2002).
19. Genoux, A., Dehondt, H., Helleboid-Chapman, A., Duhem, C., Hum, D. W., Martin, G. et al. Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORa. Arterioscler. Thromb. Vasc. Biol. 25, 1186-1192 (2005).
20. Raspé, E., Duez, H., Gervois, P., Fiévet, C., Fruchart, J.-C., Besnard, S. et al. Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORa. J. Biol. Chem. 276, 2865-2871 (2001).
21. Vu-Dac, N., Gervois, P., Grötzinger, T., De Vos, P., Schoonjans, K., Fruchart, J.-C. et al. Transcriptional regulation of apolipoprotein AI gene expression by the nuclear receptor RORa. J. Biol. Chem. 272, 22401-22404 (1997).
22. Lau, P., Fitzsimmons, R. L., Raichur, S., Wang, S. C., Lechtken, A. & Muscat, G. E. The orphan nuclear receptor, RORalpha, regulates gene expression that controls lipid metabolism: staggerer (SG/SG) mice are resistant to diet-induced obesity. J. Biol. Chem. 283, 18411-18421 (2008).
23. Mamontova, A., Seguret-Mace, S., Esposito, B., Chaniale, C., Bouly, M., Delhaye-Bouchaud, N. et al. Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation 98, 2738-2743 (1998).
24. Xu, S. C., Kuang, J. Y., Liu, J., Ma, C. L., Feng, Y. L. & Su, Z. G. Association between fibroblast growth factor 7 and the risk of chronic obstructive pulmonary disease. Acta. Pharmacol. Sin. 33, 998-1003 (2012).
25. Yuan, Y., Jiang, H., Kuang, J., Hou, X., Feng, Y. & Su, Z. Genetic variations in ADIPOQ gene are associated with chronic obstructive pulmonary disease. PLoS ONE 7, e50848 (2012).
26. GOLD, E., Committee. (Updated 2011). Global Strategy for the Diagnosis, Management and Prevention of chronic obstructive pulmonary disease, Global Initiative for Chronic Obstructive Lung Disease (GOLD). https://www.goldcopd. org.
27. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
28. Bland, J. M. & Altman, D. G. Statistics notes. The odds ratio. BMJ 320, 1468 (2000).
29. Altman, D. G. & Bland, J. M. How to obtain the confidence interval from a P value. BMJ 343, d2090 (2011).
30. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B. Stat. Methodol. 57, 289-300 (1995).
31. Shi, Y. Y. & He, L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell. Res. 15, 97-98 (2005).
32. Morris, R. W. & Kaplan, N. L. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet. Epidemiol. 23, 221-233 (2002).
33. Korb, M., Ke, Y. B. & Johnson, L. F. Stimulation of gene expression by introns: conversion of an inhibitory intron to a stimulatory intron by alteration of the splice donor sequence. Nucl. Acids Res. 21, 5901-5908 (1993).
34. Cole, J. W., Stine, O. C., Liu, X., Pratap, A., Cheng, Y., Tallon, L. J. et al. Rare variants in ischemic stroke: an exome pilot study. PLoS ONE 7, e35591 (2012).
35. Nelson, M. R., Wegmann, D., Ehm, M. G., Kessner, D. St, Jean, P., Verzilli, C. et al. An abundance of rare functional variants in 202 drug target genes sequenced in 14002 people. Science 337, 100-104 (2012).
36. Barnes, P. J. New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat. Rev. Drug Discov. 12, 543-559 (2013).
37. Garcia-Rio, F., Miravitlles, M., Soriano, J. B., Munoz, L., Duran-Tauleria, E., Sanchez, G. et al. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir. Res. 11, 63 (2010).
38. Kolsum, U., Roy, K., Starkey, C., Borrill, Z., Truman, N., Vestbo, J. et al. The repeatability of interleukin-6, tumor necrosis factor-Alpha, and C-reactive protein in COPD patients over one year. Int. J. Chron. Obstruct. Pulmon. Dis. 4, 149-156 (2009).
39. Stapleton, C. M., Jaradat, M., Dixon, D., Kang, H. S., Kim, S. C., Liao, G. et al. Enhanced susceptibility of staggerer (RORalphasg/sg) mice to lipopolysaccharide-induced lung inflammation. Am. J. Physiol. Lung. Cell. Mol. Physiol. 289, L144-L152 (2005).
40. Jaradat, M., Stapleton, C., Tilley, S. L., Dixon, D., Erikson, C. J., McCaskill, J. G. et al. Modulatory role for retinoid-related orphan receptor alpha in allergen-induced lung inflammation. Am. J. Respir. Crit. Care. Med. 174, 1299-1309 (2006).
41. Kang, H. S., Okamoto, K., Takeda, Y., Beak, J. Y., Gerrish, K., Bortner, C. D. et al. Transcriptional profiling reveals a role for RORalpha in regulating gene expression in obesity-Associated inflammation and hepatic steatosis. Physiol. Genomics 43, 818-828 (2011).
42. Delerive, P., Monte, D., Dubois, G., Trottein, F., Fruchart-Najib, J., Mariani, J. et al. The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. EMBO Rep. 2, 42-48 (2001).
43. Shi, Y., Cao, J., Gao, J., Zheng, L., Goodwin, A., An, C. H. et al. Retinoic acid-related orphan receptor-Alpha is induced in the setting of DNA damage and promotes pulmonary emphysema. Am. J. Respir. Crit. Care. Med. 186, 412-419 (2012).
44. Chen, Y., Zhu, J., Lum, P. Y., Yang, X., Pinto, S., MacNeil, D. J. et al. Variations in DNA elucidate molecular networks that cause disease. Nature 452, 429-435 (2008).